D-Wave Quantum Inc. ("D-Wave" or the "Company"), a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, today announced it has ...

Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical ...

We have now extended our global reach to around 11.5 million patients according to IQVIA numbers ... One is phases 1 and II ...

Q3 2024 Earnings Call Transcript November 6, 2024 Operator: Good day, and thank you for standing by. Welcome to the Third Quarter 2024 Novo Nordisk A/S Earnings Conference Call. At this time, all ...

According to IQVIA, global medication spending is projected ... citing disappointing Phase II trial results for its schizophrenia drug candidate ‘568 and a slowdown in prescription trends ...

All CeraVe formulas are enriched with three skin-identical ceramides (ceramides 1, 3, and 6-II), with select products ... most premium ones. *1Source: IQVIA, ProVoice Survey, rolling 12-month ...

U.S. annual sales for Estradiol Gel, 0.06% total approximately $16.7 million, based on August 2024 moving annual total (MAT) IQVIA data ... anticipated synergies, (ii) costs and regulatory ...

This has triggered change, as discussed in IQVIA’s November Africa Health Summit ... statins, and angiotensin II antagonists – had a launch every three years. Now, for major specialty care ...

And you can see this compression in the IQVIA data. So, really the shrinking ... will start entering the clinic quite soon in Phase II looking at bipolar depression and MDD as well as generalized ...

Traditional, primary care pharmacotherapies are prescribed by GPs and family doctors and treat common, chronic conditions and diseases – the leading areas being type II diabetes, asthma ...